| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | -100.0% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $31.0M | -26.2% |
| Operating Income | -$31.0M | +60.8% |
| Pre-tax Income | -$23.0M | +66.7% |
| Income Tax | $0 | -100.0% |
| Net Income | -$23.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.0M | +16.7% |
| Short-term Investments | $141.0M | +69.9% |
| Current Assets | $218.0M | +39.7% |
| Total Assets | $218.0M | +39.7% |
| Current Liabilities | $7.0M | +40.0% |
| Total Liabilities | $7.0M | +40.0% |
| Stockholders' Equity | $133.0M | -11.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.0M | +83.0% |
| Investing Cash Flow | -$52.0M | +23.5% |
| Financing Cash Flow | $72.0M | +7300.0% |
| +69.3% |
| EPS (Basic) | -$1.09 | +62.7% |
| EPS (Diluted) | -$1.09 | +62.7% |